Med. Univ. of South Carolina

Charleston, South Carolina 294253312

0 studies enrolling now · 37 studies all time

What they study most

Bacterial Infections, Candidiasis, Oral, HIV Infections, HIV Seronegativity, Locally Advanced Rectal Cancer, Lymphatic Disease, Multiple Myeloma, Pneumonia, Pneumocystis Carinii, Pregnancy, Rheumatoid Arthritis

Studies at this site

• Safety and Efficacy of Pomalidomide, Bortezomib and Low-dose Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma — Completed
• Study of Peposertib in Combination With Capecitabine and RT in Rectal Cancer — Completed
• A Study of Indinavir Sulfate Plus Zidovudine (AZT) Plus Lamivudine in HIV-Infected Patients Who Have Taken AZT for Six or More Months — Completed
• Safety and Effectiveness of Four Anti-HIV Drug Combinations in HIV-Infected Children and Teens — Completed
• A Study to Compare Different Drugs Used to Prevent Serious Bacterial Infections in HIV-Positive Children — Completed
• Comparison of New Anti-HIV Drug Combinations in HIV-Infected Children Who Have Taken Anti-HIV Drugs — Completed
• A Randomized Comparative Trial of Zidovudine (AZT) Versus 2',3'-Dideoxyinosine (ddI) Versus AZT Plus ddI in Symptomatic HIV-Infected Children — Completed
• Study of a New Anti-HIV Drug, T-20, in HIV-Infected Children — Completed
• Blood Levels of Abacavir After One Dose in HIV-Infected Children and Adolescents — Completed
• A Study of Didanosine Use Alone or in Combination With Zidovudine in Infants Exposed to or Infected With HIV — Completed
• Fortovase (Saquinavir) Given With Low-Dose Ritonavir, Zidovudine, and Lamivudine to HIV-Positive Pregnant Women During and After Pregnancy and to Their Newborns — Completed
• The Safety and Effectiveness of Zidovudine in HIV-Infected Pregnant Women and Their Infants — Completed
• A Study to Compare Two Different Anti-HIV Drug Regimens — Completed
• A Study on the Management of Combination Anti-HIV Drug Therapy in HIV-Positive Children With Prior Treatment — Completed
• A Study to Compare Two Anti-HIV Combination Therapies Each Containing Saquinavir in HIV-Positive Children — Completed
• A Phase III Study to Evaluate the Safety, Tolerance, and Efficacy of Early Treatment With Zidovudine (AZT) in Asymptomatic Infants With HIV Infection — Completed
• A Study of Nevirapine for the Prevention of HIV Transmission From Mothers to Their Babies — Completed
• Safety and Effectiveness of Giving Indinavir Plus Stavudine Plus Lamivudine to HIV-Infected Children — Completed
• A Comparative Study of Combination Antiretroviral Therapy in Children and Adolescents With Advanced HIV Disease — Completed
• A Study to Evaluate the Safety and Tolerability of Zidovudine (ZDV) in Premature Infants Born to HIV-Positive Women. — Completed
• Efficacy and Safety Study of CC-292 Versus Placebo as Co-therapy With Methotrexate in Active Rheumatoid Arthritis — Completed
• A Study on the Effect of High-Calorie Infant Formula on Growth and Nutrition in HIV-Infected Infants — Completed
• Long-Term Effects of HIV Exposure and Infection in Children — Completed
• A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients — Completed
• A Comparison of Zidovudine Plus Lamivudine Versus ddI Used Alone or in Combination With Zidovudine in HIV-1 Infected Children — Completed
• A Study on the Rate of Opportunistic (AIDS-Related) Infections Among HIV-Positive Children Who Have Stopped Taking Their OI Preventive Medications — Completed
• A Phase III Randomized, Double-Blind, Controlled Study of the Use of Anti-HIV Immune Serum Globulin (HIVIG) for the Prevention of Maternal-Fetal HIV Transmission in Pregnant Women and Newborns Receiving Zidovudine (AZT) — Completed
• A Blood Test to Look at Cells of the Immune System in Healthy Children — Completed
• Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients — Paused
• A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega — Completed
• The Efficacy and Safety of Retrovir in Patients Infected With HIV Who Are Asymptomatic (CDC Group II) or Have Persistent Generalized Lymphadenopathy (CDC Group III) — Completed
• A Double-Blind, Randomized, Comparative Study of Delavirdine Mesylate (U-90152S) in Combination With Didanosine (ddI) Versus ddI Alone in HIV-1 Infected Individuals With CD4 Counts of <= 300/mm3 — Completed
• A Double-Blind, Randomized, Dose Response Study of Three Doses of Delavirdine Mesylate (U-90152S) in Combination With Zidovudine (ZDV) Versus ZDV Alone in HIV-1 Infected Individuals With CD4 Counts of 200-500mm3 — Completed
• Safety and Effectiveness of Adding Adefovir Dipivoxil and Nelfinavir to the Anti-HIV Therapy of HIV-Infected Children — Status unconfirmed
• A "Pre-Enrollment" Protocol for HIV-Infected Adolescents — Completed
• The Safety and Effectiveness of Zidovudine Plus Lamivudine, Used With and Without 1592U89, in HIV-1 Infected Children Who Have Taken Anti-HIV-1 Drugs — Completed
• Safety and Effectiveness of Fluconazole Versus SCH 56592 to Treat Thrush in HIV-Positive Patients — Completed